Phase 0
Showing 1 - 25 of >10,000
Metastatic Castration-resistant Prostate Cancer Trial in Oslo (212Pb-NG001)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
-
Oslo, NorwayOslo University Hospital
Feb 13, 2023
Glioblastoma Multiforme, Adult, Recurrent Glioblastoma Trial in Rotterdam (Pitavastatin calcium)
Not yet recruiting
- Glioblastoma Multiforme, Adult
- Recurrent Glioblastoma
- Pitavastatin calcium
-
Rotterdam, NetherlandsErasmus MC
Aug 3, 2023
Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme of Brain Trial in Hershey (Posaconazole Pill)
Recruiting
- Glioblastoma
- +3 more
- Posaconazole Pill
-
Hershey, PennsylvaniaPenn State Milton S Hershey Medical Center
Aug 5, 2022
Glioblastoma Multiforme, Glioma of Brain Trial in Chandler, Phoenix, Scottsdale (Ribociclib, Everolimus)
Completed
- Glioblastoma Multiforme
- Glioma of Brain
-
Chandler, Arizona
- +2 more
Jan 11, 2023
Cognition Disorder, Alzheimer Trial in Uppsala (ACD856)
Completed
- Cognition Disorder
- Alzheimer Disease
-
Uppsala, SwedenUppsala University Hospital
Mar 23, 2023
Solid Tumor Trial in United States (drug, combination product, biological)
Recruiting
- Solid Tumor
- Pembrolizumab
- +2 more
-
Sacramento, California
- +6 more
Jan 3, 2023
Pyoderma, Pyoderma Gangrenosum, Pyoderma Vegetans Trial in Minsk, Riga (Monoclonal antibody (Mab) sB24M)
Active, not recruiting
- Pyoderma
- +3 more
- Monoclonal antibody (Mab) sB24M
-
Minsk, Belarus
- +1 more
Jul 8, 2022
Uterine Cervix Cancer Trial (Standard)
Not yet recruiting
- Uterine Cervix Cancer
- Standard
- (no location specified)
Jul 13, 2022
Advanced Solid Tumor Trial in Boston (TTX-MC138-NODAGA-Cu64)
Recruiting
- Advanced Solid Tumor
-
Boston, MassachusettsMassachusetts General Hospital
Jun 14, 2023
High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)
Not yet recruiting
- High Grade Glioma
- +3 more
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Mar 6, 2023
Glioma Trial in Melbourne (Biopsy, Part A: AB-218, Surgery (maximal resection))
Recruiting
- Glioma
- Biopsy
- +3 more
-
Melbourne, Victoria, AustraliaRoyal Melbourne Hospital
Oct 11, 2022
Rotavirus Infections, Diarrhea Trial (IRV on a 0- and 28-day schedule, IRV on a 0-, 28- and 56-day schedule, Placebo on Day 0,
Not yet recruiting
- Rotavirus Infections
- Diarrhea
- IRV on a 0- and 28-day schedule
- +3 more
- (no location specified)
Oct 8, 2023
Low-grade Glioma, IDH2 Gene Mutation, Recurrent Glioma Trial in Boston (Niraparib, Resection/Treatment with Niraparib)
Recruiting
- Low-grade Glioma
- +4 more
- Niraparib
- Resection/Treatment with Niraparib
-
Boston, MassachusettsMassachusetts General Hospital
Oct 19, 2022
Malignant Glioma, Glioblastoma Trial in Durham (Evolocumab)
Recruiting
- Malignant Glioma
- Glioblastoma
-
Durham, North CarolinaDuke University Medical Center
Oct 13, 2022
Hemorrhage Trial in Fort Worth (0 Hz Control, 0.1 Hz PPT, 0.05 Hz PPT)
Completed
- Hemorrhage
- 0 Hz Control
- +2 more
-
Fort Worth, TexasUniversity of North Texas Health Science Center
Aug 1, 2023
Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme, Adult Trial in Phoenix (Pamiparib, Olaparib, Radiation therapy)
Recruiting
- Glioblastoma
- +2 more
- Pamiparib
- +3 more
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
May 3, 2022
Glioblastoma, Glioma, Glioblastoma Multiforme Trial in Phoenix (AZD1390)
Recruiting
- Glioblastoma
- +3 more
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Mar 10, 2022
Exocrine Pancreatic Cancer Trial in Oklahoma City (Omeprazole)
Recruiting
- Exocrine Pancreatic Cancer
-
Oklahoma City, OklahomaStephenson Cancer Center
Jan 9, 2023
High Grade Glioma Trial in Phoenix (SONALA-001(ALA) and MR-Guided Focused Ultrasound device (MRgFUS))
Recruiting
- High Grade Glioma
- SONALA-001(ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
- MR-Guided Focused Ultrasound device (MRgFUS)
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Dec 22, 2022
Endometrial Cancer, Serous Adenocarcinoma, Uterine Tumor Trial (Niraparib oral capsule)
Not yet recruiting
- Endometrial Cancer
- +2 more
- Niraparib oral capsule
- (no location specified)
Oct 31, 2022
Colo-rectal Cancer Trial (biological, drug, procedure)
Not yet recruiting
- Colo-rectal Cancer
- Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
- +8 more
- (no location specified)
Aug 28, 2023